 | • レポートコード：B-MOR-08118 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、臨床意思決定支援システム（CDSS）の世界市場について調べ、臨床意思決定支援システム（CDSS）の世界規模、市場動向、市場環境、モデル別（ナレッジベース、非ナレッジベース、その他）分析、導入モード別（Webベース、クラウドベース、オンプレミス）分析、コンポーネント別分析、製品別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・臨床意思決定支援システム（CDSS）の世界市場インサイト ・臨床意思決定支援システム（CDSS）の世界市場環境 ・臨床意思決定支援システム（CDSS）の世界市場動向 ・臨床意思決定支援システム（CDSS）の世界市場規模 ・臨床意思決定支援システム（CDSS）の世界市場規模：モデル別（ナレッジベース、非ナレッジベース、その他） ・臨床意思決定支援システム（CDSS）の世界市場規模：導入モード別（Webベース、クラウドベース、オンプレミス） ・臨床意思決定支援システム（CDSS）の世界市場規模：コンポーネント別 ・臨床意思決定支援システム（CDSS）の世界市場規模：製品別 ・臨床意思決定支援システム（CDSS）の世界市場規模：用途別 ・臨床意思決定支援システム（CDSS）の世界市場：地域別市場規模・分析 ・臨床意思決定支援システム（CDSS）の北米市場規模・予測 ・臨床意思決定支援システム（CDSS）のアメリカ市場規模・予測 ・臨床意思決定支援システム（CDSS）のヨーロッパ市場規模・予測 ・臨床意思決定支援システム（CDSS）のアジア市場規模・予測 ・臨床意思決定支援システム（CDSS）のインド市場規模・予測 ・臨床意思決定支援システム（CDSS）の韓国市場規模・予測 ・関連企業情報・競争状況 |
The clinical decision support systems market is expected to grow at a CAGR of about 11% during the forecast period. Physicians, nurses, and other healthcare professionals use CDSS to perform diagnosis and to review the diagnosis as a means of improving the result. Data mining may be piloted to examine the medical history of patients in combination with appropriate clinical research. Such examination can help predict possible events, which can range from drug interactions to disease symptoms. Some physicians prefer to evade over-consulting their CDSS, relying instead on their professional skill to determine the best course of care.
Need for Reducing Human Errors
Determining accurate medication doses is a difficult and time-consuming process and especially critical for infants and children in emergency situations. Calculations involving intricate formulas are often difficult to memorize, and mathematical errors can still occur even when the formulas are accurately recalled. Varying dosing programs based on indication and pharmacokinetics represent additional opportunities for error. Clinical decision support systems can give physicians and nurses easy and quick access to drug-specific dosing calculators, full drug profiles with age, weight, disease and renal adjustment dosing, and much more. Accurate medication information and dosing calculators, easily accessible within the medical workflow, can provide a significant reduction in errors. Owing to these capabilities of the system, there will be a boost in the growth of the clinical decision support systems market. Other factors that will affect the growth of this market include accumulative government support, rising demand to reduce healthcare expenditure, need for improvement in quality of care, rising chronic disease population, and emerging economies posting significant growth.
Lack of Trust in the System as CDSS is in its Initial Stages of Development
The most often recurring barriers to CDSS implementation included earlier experience of dysfunctional computer systems in health care, general resistance towards changes in practice, and time management issues. In a study conducted by Oxford University, all groups listed numerous examples of dysfunctional healthcare IT systems, and they were worried of consequences if CDSS is built on the existing imperfect systems. This lack of trust in the healthcare professionals will lead to them not including for CDSS in their practice. This will eventually lead to the slowdown of the growth of this market. Other factors that will influence the decline of this market include lack of skilled labor, suggestions from CDSS for unnecessary diagnostic testing, and saturated end user market will hinder the market growth.
North America to Maintain Dominance
North America is the leading market in the world, followed by Europe. Asia-Pacific is the fastest developing region. The large market share of North America can be attributed to factors such as the rising demand for quality healthcare delivery, need to curb increasing healthcare expenditure, and implementation of favorable initiatives & regulations are driving the growth of the CDSS market in the United States.
Key Developments in the Market:
• February 2018 – The US Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first artificial intelligence-based clinical decision support (CDS) solution cleared for sale in the United States. Viz.AI Contact is designed to analyze computed tomography (CT) results.
Major Players: CERNER CORPORATION, EPIC, IBM, MCKESSON CORPORATION, MEDITECH, PHILLIPS HEALTHCARE, AND SIEMENS HEALTHCARE, amongst others.
Reasons to Purchase the Report
• Current and future clinical decision support systems market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Need for Reducing Human Errors
6.1.2 Increasing Government Support
6.1.3 Rising Demand to Reduce Healthcare Expenditure
6.1.4 Need for Improvement in Quality of Care
6.1.5 Rising Chronic Disease Population
6.1.6 Emerging Economies Posting Significant Growth
6.2 Market Restraints
6.2.1 Lack of Skilled Labor
6.2.2 Suggestions from CDSS for Unnecessary Diagnostic Testing
6.2.3 Lack of Trust in the System due to CDSS being in its Initial Stages of Developement
6.2.4 Saturated End User Market
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Model
7.1.1 Knowledge-based CDSS
7.1.2 Non-Knowledge CDSS
7.1.3 Others
7.2 By Mode of Delivery
7.2.1 Web-based
7.2.2 Cloud-based
7.2.3 On-premise
7.3 By Component
7.3.1 Hardware
7.3.2 Software
7.3.3 Services
7.4 By Product
7.4.1 Integrated Systems
7.4.2 Standalone Systems
7.4.3 Standard-based
7.4.4 Service model-based
7.4.5 Others
7.5 By Application
7.5.1 Medical Diagnosis
7.5.2 Alerts & Reminders
7.5.3 Prescription Decision Support
7.5.4 Information Retrieval
7.5.5 Image Recognition and Interpretation
7.5.6 Therapy Critiquing & Planning
7.5.7 Others
7.6 By Geography
7.6.1 North America
7.6.1.1 United States
7.6.1.2 Canada
7.6.1.3 Mexico
7.6.2 Europe
7.6.2.1 France
7.6.2.2 Germany
7.6.2.3 United kingdom
7.6.2.4 Italy
7.6.2.5 Spain
7.6.2.6 Rest of Europe
7.6.3 Asia-Pacific
7.6.3.1 India
7.6.3.2 Australia & New Zealand
7.6.3.3 South Korea
7.6.3.4 Rest of Asia-Pacific
7.6.4 Rest of the World
7.6.4.1 Saudi Arabia
7.6.4.2 Brazil
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Cerner Corporation
9.2 EPIC
9.3 IBM
9.4 Mckesson Corporation
9.5 Meditech
9.6 Phillips Healthcare
9.7 Siemens Healthcare
9.8 List Not Exhaustive
10. Future of the Market